Multi-stakeholder workshop to launch consultation on European Medicines Agency (EMA) veterinary regulatory science to 2025

• Date:
  Thursday, 6 December 2018, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

This multi-stakeholder workshop aims to gather initial thoughts on the key areas to be covered in the current reflection on EMA’s Regulatory Science to 2025 and will share proposals for veterinary medicines.

This aims to facilitate:

• a shared reflection on the key regulatory science faced by the various scientific committees and working parties of the Agency and opportunities to address these;
• an understanding of the process by which the proposed strategic goals and core recommendations were elaborated to date; 
• highlight areas of particular relevance to various stakeholder groups to focus on during the public consultation.

The participants will include veterinarians, academic infrastructures, trade associations and regulators.

The event is by invitation-only to allow for a fair distribution across stakeholders.

It will be broadcast live which interested parties can follow on this page. The recording will be available after the workshop.

Documents

Agenda - Regulatory science to 2025: launch of veterinary stakeholder consultation

Draft Reference Number: EMA/780555/2018

Presentation - Session 1: Regulation of veterinary medicinal products in the 21st century: addressing challenges and opportunities across the European Regulatory Framework (Ivo Claassen)

Presentation - Session 1: Integration of Agency Committees and Network into delivery of the strategy (David Murphy)

Presentation - Session 1: Regulatory Science to 2025: view from the European Commission (Christian Siebert)

Presentation - Session 1: View from European Medicines Regulatory Network (Jean-Pierre Orand)

Presentation - Session 1: Challenges and opportunities across theregulatory framework: view from veterinarians (Nancy De Briyne)

Presentation - Session 1: Challenges and opportunities across the European Regulatory Framework: view for the animal medicines industry (Alexander Böttner)

Presentation - Session 2: Veterinary vaccines: proposal to facilitate licensing in general (Carmen Jungbaeck)

Presentation - Session 2: Catalysing the integration of science and technology in drug development (Rory Breathnach)

Presentation - Session 2: Catalysing the integration of science and technology in development (Jackie Atkinson)

Presentation - Session 2: Association of Veterinary Consultants (Klaus Hellmann)

Presentation - Session 2: RS to 2025: catalysing the integration of science and technology in drug development (Lindsay Marshall)

Presentation - Session 3: Driving collaborative evidence generation and improving the scientific quality of evaluations (Nicholas Jarrett)

Presentation - Veterinary Stakeholders Workshop: European Group for Generic Veterinary Products (EGGVP) (Elsa Vecino)

Presentation - Session 3: Driving collaborative evidence generation: improving the scientific quality of evaluations (Jaques Lechenet)

Presentation - Session 4: Addressing emerging health threats and availability/therapeutic challenges (Helen Jukes)

Presentation - Session 4: Addressing emerging health threats and availability/therapeutic challenges (Alexander Boettner)

Presentation - Session 4: Veterinary vaccines: proposal to facilitate licensing in exceptional circumstances (emergency) (Carmen Jungbaeck)

Presentation - Session 4: Addressing emerging health threats and availability/therapeutic challenges (Georg von Samson-Himmelstjerna)

Presentation - Session 4: Addressing emerging health threats and availability/therapeutic challenges (Rens van Dobbenburgh)

Presentation - Session 5: Enabling and leveraging research and innovation in regulatory science (Tony Humphreys)

Video recording